Cell aggregation enhances bone formation by human mesenchymal stromal cells.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
LaPointe, V L
van Blitterswijk, C A
de Beor, J
MetadataShow full item record
AbstractThe amount of bone generated using current tissue engineering approaches is insufficient for many clinical applications. Previous in vitro studies suggest that culturing cells as 3D aggregates can enhance their osteogenic potential, but the effect on bone formation in vivo is unknown. Here, we use agarose wells to generate uniformly sized mesenchymal stromal cell (MSC) aggregates. When combined with calcium phosphate ceramic particles and a gel prepared from human platelet-rich plasma, we generated a tissue engineered construct which significantly improved in vivo bone forming capacity as compared to the conventional system of using single cells seeded directly on the ceramic surface. Histology demonstrated the reproducibility of this system, which was tested using cells from four different donors. In vitro studies established that MSC aggregation results in an up-regulation of osteogenic transcripts. And finally, the in vivo performance of the constructs was significantly diminished when unaggregated cells were used, indicating that cell aggregation is a potent trigger of in vivo bone formation by MSCs. Cell aggregation could thus be used to improve bone tissue engineering strategies.
CitationCell aggregation enhances bone formation by human mesenchymal stromal cells. 2017, 33:121-129 Eur Cell Mater
AffiliationHemholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Vraunschweig, Germany.
JournalEuropean cells & materials
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/
- Engineering new bone via a minimally invasive route using human bone marrow-derived stromal cell aggregates, microceramic particles, and human platelet-rich plasma gel.
- Authors: Chatterjea A, Yuan H, Fennema E, Burer R, Chatterjea S, Garritsen H, Renard A, van Blitterswijk CA, de Boer J
- Issue date: 2013 Feb
- Stromal-cell-derived extracellular matrix promotes the proliferation and retains the osteogenic differentiation capacity of mesenchymal stem cells on three-dimensional scaffolds.
- Authors: Antebi B, Zhang Z, Wang Y, Lu Z, Chen XD, Ling J
- Issue date: 2015 Feb
- Parameters in three-dimensional osteospheroids of telomerized human mesenchymal (stromal) stem cells grown on osteoconductive scaffolds that predict in vivo bone-forming potential.
- Authors: Burns JS, Rasmussen PL, Larsen KH, Schrøder HD, Kassem M
- Issue date: 2010 Jul
- Bioreactor culture duration of engineered constructs influences bone formation by mesenchymal stem cells.
- Authors: Mitra D, Whitehead J, Yasui OW, Leach JK
- Issue date: 2017 Nov
- Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics.
- Authors: Kasten P, Vogel J, Luginbühl R, Niemeyer P, Weiss S, Schneider S, Kramer M, Leo A, Richter W
- Issue date: 2006